COCRYSTAL PHARMA, INC. Marketable Securities, Realized Gain (Loss), Excluding Other-than-temporary Impairment Loss
COCRYSTAL PHARMA, INC. (COCP) reported Marketable Securities, Realized Gain (Loss), Excluding Other-than-temporary Impairment Loss of -$1.69 million for the 9-month period ending 2015-09-30, per its 10-Q filed 2016-11-09.
Discontinued › Income Statement › Other Income
us-gaap:MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments · last filed 2016-11-09
- COCRYSTAL PHARMA, INC. marketable securities, realized gain (loss), excluding other-than-temporary impairment loss for the quarter ending 2015-09-30 was -$1.00K.
- COCRYSTAL PHARMA, INC. marketable securities, realized gain (loss), excluding other-than-temporary impairment loss for the quarter ending 2014-09-30 was $0.00.
| Period end | Marketable Securities, Realized Gain (Loss), Excluding Other-than-temporary Impairment Loss 3 month | Marketable Securities, Realized Gain (Loss), Excluding Other-than-temporary Impairment Loss 6 month | Marketable Securities, Realized Gain (Loss), Excluding Other-than-temporary Impairment Loss 9 month |
|---|---|---|---|
| 2015-09-30 | -$1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | -$1.69M 10-Q · filed 2016-11-09 | |
| 2015-06-30 | -$1.69M 10-Q · filed 2016-08-09 | ||
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-16 | $480.00K 10-Q · filed 2015-11-16 | |
| 2014-06-30 | $480.00K 10-Q · filed 2015-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |